21356-Lymphomas-NA-1617

Lymphomas

AN OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SUBCUTANEOUS MOSUNETUZUMAB MONOTHERAPY IN PATIENTS WITH SELECT B-CELL MALIGNANCIES (ML43389)

  • Details

ClinicalTrials.gov ID: NCT05207670
Diagnosis Type: NA
USOR Number:

  • Address

6031 East Woodmen Road, Suite 200
Colorado Springs, CO 80923
P: (719) 577-2555

Search by practice name, trial titles, indicators and specific disease types.